Pure Global

Drug Test for Qualitative Analysis of Cells Expressing HLA-DR Antigen - Vietnam Registration 2401177ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Drug Test for Qualitative Analysis of Cells Expressing HLA-DR Antigen in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2401177ĐKLH/BYT-HTTB and manufactured by Immunotech SAS. The authorized representative in Vietnam is CÔNG TY TNHH KỸ THUẬT NAM PHƯƠNG.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2401177ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2401177ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Drug Test for Qualitative Analysis of Cells Expressing HLA-DR Antigen
VN: Thuốc thử xét nghiệm định tính các tế bào biểu hiện kháng nguyên HLA-DR
Risk Class TTBYT Loại C

Registration Details

2401177ĐKLH/BYT-HTTB

000.00.04.G18-211129-0023

Anti-HLA-DR-Pacific Blue

B36291

Company Information

FRANCE

Beckman Coulter, Inc.

Technical Details

Anti-HLA-DR-Pacific Blue, a combined antibody with fluorescent dye, enables the qualitative and quantitative determination of cell populations expressing the HLA-DR antigen in human biological samples using flow cytometry.

Dates and Status

Jul 22, 2024